JPRN-UMIN000009698已完成未知
Phase II crinical trial of cetuximab rechallenge with KRAS wild-type unresectable/recurrent colorectal cancer - Cetuximab Rechallenge
Okayama Molecular Target-Based Drugs Society for Cancer of the Colon and Rectum0 个研究点目标入组 25 人开始时间: 2013年1月7日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Synchronous or metachronous (within 5 years) malignancy other than carcinoma in situ 2)Patients with brain metastasis which have symptoms or patients with history of brain metastasis 3)Severe wattery diarrhea 4)Severe infectious disease 5)Severe complications (interstitial lung disease or pulmonary fibrosis, kidney failure, hepatic failure, uncontrolable diabetes, uncontrolable hypertension) 6)Severe carcinomatous ascites, pleural effusion or pericardial cavity effusion 7)Pregnant or lactating women or women of childbearing potential, and no birth-control 8)Patients with history of serious hypersensitivity
研究者
相似试验
已完成
2 期
Phase II study of cetuximab rechallenge in the third-line therapy in patients with KRAS wild-type metastatic colorectal cancerJPRN-UMIN000010638Japan Clinical Cancer Research Organization35
进行中（未招募）
不适用
Randomized phase II feasibility study of Cetuximab combined with 4 cycles of TPF followed by platinum based chemo-radiation strategiesHistologically proven newly diagnosed unresectable squamous cellcarcinoma of the head and neckEUCTR2006-004189-14-HUEORTC50
已完成
2 期
Randomized phase II feasibility study of Cetuximab combined with 4 cycles of TPF followed by platinum based chemo-radiation strategieshead and neck carcinomalaryngeal cancer10027655NL-OMON32191EORTC10
进行中（未招募）
1 期
Randomized phase II feasibility study of Cetuximab combined with 4 cycles of TPF followed by platinum based chemo-radiation strategiesEUCTR2006-004189-14-NLEORTC
进行中（未招募）
不适用
Randomized phase II feasibility study of Cetuximab combined with 4 cycles of TPF followed by platinum based chemo-radiation strategiesHistologically proven newly diagnosed unresectable squamous cellcarcinoma of the head and neckEUCTR2006-004189-14-BEEORTC50